Abstract Number: 2347 • 2019 ACR/ARP Annual Meeting
Long-term Survival in Lung Transplantation and Allograft Rejection in Patients with Interstitial Lung Disease Related with Rheumatoid Arthritis: Study from a Single Referral Center
Background/Purpose: Interstitial lung disease (ILD) is a leading cause of death in patients with rheumatoid arthritis (RA). In end-stage RA-ILD, lung transplant becomes the only…Abstract Number: 523 • 2018 ACR/ARHP Annual Meeting
The Prevalence and Clinical Characteristics of Rheumatoid Arthritis with Interstitial Lung Disease in the San Joaquin Valley of Central California
Background/Purpose: Rheumatoid Arthritis (RA) is an autoimmune disease of systemic inflammation primarily involving the small synovial joints. Approximately 1.5 million adults in the United States…Abstract Number: 524 • 2018 ACR/ARHP Annual Meeting
Clinical Course of Interstitial Lung Disease in Rheumatoid Arthritis Patients in Clinical Practice
Background/Purpose: Interstitial lung disease (ILD) is the extra-articular manifestation that most frequently worsens the course of Rheumatoid arthritis (RA) disease. Purpose: To describe the characteristics…Abstract Number: 527 • 2018 ACR/ARHP Annual Meeting
Long-Term Follow up of Subclinical Interstitial Lung Disease in Rheumatoid Arthritis
Background/Purpose: Using of high-resolution computed tomography(HRCT) has increased the early detection of interstitial lung disease(ILD) in asymptomatic and undiagnosed individuals. This study was to identify…Abstract Number: 542 • 2018 ACR/ARHP Annual Meeting
Incidence and Prevalence of Interstitial Lung Disease in the US Population and in Patients with RA By Anti-Citrullinated Protein Antibody Status
Background/Purpose: Interstitial lung disease (ILD) is recognized as the most common pulmonary extra-articular manifestation of RA. The hazard ratio for 30-year risk of ILD in…Abstract Number: 1819 • 2018 ACR/ARHP Annual Meeting
MUC5B promoter Variant rs35705950 Is a Risk Factor for Rheumatoid Arthritis – Interstitial Lung Disease
Background/Purpose: Given phenotypic similarities between rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and idiopathic pulmonary fibrosis (IPF), we hypothesized that the strongest risk factor for the…Abstract Number: 2045 • 2018 ACR/ARHP Annual Meeting
Specific Anti-Citrullinated Protein Antibodies Profiles Are Associated with Rheumatoid Arthritis Related Interstitial Lung Disease
Background/Purpose: The identification of peripheral blood markers of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) may facilitate an earlier diagnosis and provide insight regarding the pathogenesis…Abstract Number: 137 • 2017 ACR/ARHP Annual Meeting
Rheumatoid Arthritis and the Risk for Interstitial Lung Disease: A Comparison of Risk Associated with Biologic and Conventional Dmards
Background/Purpose: Interstitial Lung Disease (ILD) is a rare but often severe consequence of several rheumatologic conditions including rheumatoid arthritis (RA). The comparative risk of incident…Abstract Number: 478 • 2017 ACR/ARHP Annual Meeting
Ectopic Lymphoid Tissue in the Lung Is Uniquely Associated with the ACPA IgA Isotype Even in Absence of Classifiable RA
Background/Purpose: Antibodies to citrullinated protein antigens (ACPA) precede the development of rheumatoid arthritis (RA) and may be generated in the lung of established and preclinical…Abstract Number: 2009 • 2017 ACR/ARHP Annual Meeting
Quantitative Radiographic Analysis of Interstitial Lung Disease Associated with Rheumatoid Arthritis
Background/Purpose: Quantitative analysis of fibrotic patterns provides an objective measurement of treatment efficacy in interstitial lung disease (ILD). We aimed to measure the extent of…Abstract Number: 2915 • 2017 ACR/ARHP Annual Meeting
Increased Expression of Malondialdehyde-Acetaldehyde Adducts (MAA) and Anti-Maa Antibody in Rheumatoid Arthritis-Interstitial Lung Disease
Background/Purpose: Generated under oxidative stress, malondialdehyde-acetaldehyde adducts (MAA), and antibody responses to MAA appear to facilitate loss of immune tolerance and generate pro-inflammatory responses in…Abstract Number: 1500 • 2016 ACR/ARHP Annual Meeting
Concomitant Development of Interstitial Pneumonia Associated with Dermatomyositis and Rheumatoid Arthritis
Background/Purpose: A few cases of the concomitant development of interstitial pneumonia associated with dermatomyositis (DM-IP) and rheumatoid arthritis (RA) have been reported mainly in Asia,…Abstract Number: 576 • 2016 ACR/ARHP Annual Meeting
Anti-CCP3.1 and Anti-CCP3-IgA Are Elevated in RA-Free Subjects with Idiopathic Pulmonary Fibrosis
Background/Purpose: In RA-associated interstitial lung disease (RA-ILD), higher levels of anti-CCP antibodies have been associated with the presence and severity of ILD suggesting a potential…Abstract Number: 1498 • 2016 ACR/ARHP Annual Meeting
Patterns of Interstitial Lung Disease and Associated Mortality in Rheumatoid Arthritis
Background/Purpose: To characterize a cohort of patients with rheumatoid arthritis (RA) who have interstitial lung disease (ILD) and to assess the utility of the GAP…Abstract Number: 616 • 2015 ACR/ARHP Annual Meeting
Risk Factors for the Exacerbation of Interstitial Lung Disease (ILD) after Administration of Biologic Dmards in RA Patients with Pre-Existing ILD
Background/Purpose: Interstitial lung disease (ILD) associated with RA is a big concern particularly in Japanese patients evidenced by the reports that the cause of death…